FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Kisunla (donanemab-azbt) - July 02, 2024
- Ahzantive (aflibercept-mrbb) - June 28, 2024
- Nypozi (filgrastim-txid) - June 28, 2024
- Pyzchiva (ustekinumab-ttwe) - June 28, 2024
- Ohtuvayre (ensifentrine) - June 26, 2024
- Tepylute (thiotepa) - June 25, 2024
- PiaSky (crovalimab-akkz) - June 20, 2024
- Sofdra (sofpironium) - June 18, 2024
- Capvaxive (pneumococcal 21-valent conjugate vaccine) - June 17, 2024
- Vigafyde (vigabatrin) - June 17, 2024
- Yimmugo (immune globulin intravenous, human-dira) - June 13, 2024
- Iqirvo (elafibranor) - June 10, 2024
- Rytelo (imetelstat) - June 06, 2024
- mRESVIA (respiratory syncytial virus vaccine, mRNA) - May 31, 2024
- Bkemv (eculizumab-aeeb) - May 28, 2024
- Onyda XR (clonidine hydrochloride) - May 24, 2024
- Opuviz (aflibercept-yszy) - May 20, 2024
- Yesafili (aflibercept-jbvf) - May 20, 2024
- Imdelltra (tarlatamab-dlle) - May 16, 2024
- Myhibbin (mycophenolate mofetil) - May 01, 2024